Author: Carole Bartoo
Fellow tracks post-vaccination bacterial trends
Oct. 17, 2013—Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines.
Student’s neurosurgical fellowship spurs research
Oct. 10, 2013—Travis Ladner, a third-year student at the Vanderbilt University School of Medicine, has been selected for a 2013 Congress of Neurological Surgeons (CNS) student fellowship award. The award is presented to a medical student every year from a national pool of applicants.
Clinic creates path to better heart health for older patients
Oct. 10, 2013—Thomas Kent has never met a stranger. He is quick to share tales about his time as a music manager in Las Vegas or to pull out one of his favorite one-liners. He says he’s the only Quaker minister in town with a wife behind the pulpit to strike a “bada-bing” after each joke.
VUSM student lands Physicians of Tomorrow Award from AMA
Oct. 3, 2013—Michele Luhm Vigor, a member of Vanderbilt University School of Medicine’s Class of 2014, has been selected by the American Medical Association (AMA) Foundation to receive a Physicians of Tomorrow Award.
UCSF’s King to deliver annual Levi Watkins Jr. Lecture
Oct. 3, 2013—Talmadge King Jr., M.D., chair of the Department of Medicine at the University of California, San Francisco, will deliver Vanderbilt University School of Medicine's 12th annual Levi Watkins Jr. Lecture at noon on Tuesday, Oct. 15, in 208 Light Hall.
Vaccine Research Program lands major NIH renewal
Sep. 26, 2013—The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.
VU testing vaccine against new flu threat
Sep. 19, 2013—Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.
Options to treat childhood C. diff. infection studied
Sep. 12, 2013—After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections.
Controversial info release aids VUMC bird flu research
Sep. 5, 2013—Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin.
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
Speed, focus serve nurse in the clinic and on the track
Aug. 22, 2013—Stephanie Duke, LPN, is quick and focused when she moves from patient to patient at the Vanderbilt Hillsboro Medical Group clinic. She says there is plenty going on here to keep her interest.
Vaccine researchers ready as new flu strain evolves
Aug. 22, 2013—A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China.
